Remove 2011 Remove Competition Remove Leads
article thumbnail

Sorry, the Inflation Bill won’t lower healthcare costs

World of DTC Marketing

This is going to lead to a lot of health problems and associated costs. Data from the Kaiser Family Foundation (KFF) shows that between 2011 and 2021, the average premiums for family coverage rose from $15,073 to $22,221—an increase of 47.4%. 1ne: A new analysis predicts that by 2030, 48.9% will be severely obese. percent of U.S.

article thumbnail

Understanding the evidence used in drug product withdrawals

European Pharmaceutical Review

Between 1999 and 2001, it supported 17 percent of withdrawals, between 2002 and 2011, it supported 26 percent of withdrawals and by 2012 to 2016, 80 percent of withdrawals were supported by observational studies (cohort, case-control, or other epidemiologic design). Meta-analyses contributed least frequently (31.4 EMA/95098/2010.

Medicine 116
article thumbnail

The EU HTA regulation: a new frontier for access to innovative technologies

European Pharmaceutical Review

To achieve this objective, the regulation amends Directive 2011/24/EU on the application of patients’ rights in cross?border Article 15 proved that transparent and effective assessments of new technologies were crucial to ensure fair competition between stakeholders that operate in the EU. effectiveness and therapeutic efficacy.

article thumbnail

Achieving scale up success under economic uncertainty

European Pharmaceutical Review

Market uncertainty Rising operational costs, stiffening competition, ongoing patent expirations, evolving environmental and social governance requirements and increasing pressure on drug prices mean the industry will have to navigate thoughtfully to be successful amid this complicated mix of financial and strategic risks. Ventola CL.

article thumbnail

Industry Leader Julie Adrian Appointed by FINN Partners to Accelerate Growth of Agency’s UK Health Group

PM360

17, 2024 – FINN Partners, one of the world’s leading independent marketing and communications agencies, today announces the appointment of Julie Adrian as Managing Partner and UK Health Group Lead. In the newly created position, Adrian reports to Gil Bashe, Chair FINN Global Health and Purpose.

Leads 52
article thumbnail

Botanical drugs – what is the best way forward for regulatory and market approval?

European Pharmaceutical Review

Herbal medicines placed on the market since April 2011 must have either a traditional herbal registration (THR) or a Marketing Authorisation (MA). Prior to joining Fieldfisher, Taly spent four years working as in-house counsel for a leading tech company helping launch products across multiple EU markets. 2012/1916).

Marketing 103
article thumbnail

The Fastest Growing Companies in Boston Hiring For Sales

CloserIQ

Founded 2011. Founded 2011. They’ve worked with leading clients such as Twitter and Mercedes Benz. Cybereason’s workplace culture is known to be fast-paced and competitive, with plenty of opportunities for learning. Founded 2011. 101-250 employees. million in funding. See open roles. 501-1000 employees.

Sales 76